I have followed biotechs for years & this company's products seem sound.
Further validation data is due this month from a trial held in Australia.
One thing we have to accept is, the higher the sp climbs, the more downrampers will be attracted to this board. Valid points are worth replying to, but just ignore the rest.
- Forums
- ASX - By Stock
- SLA
- aktsier on the money